---
version: 1.0
last_updated: 2026-10-11
project: ATS
owner: MA
category: guide
status: active
dependencies:
  - path: ../user/REQ-20261011-ATS-006.md
    reason: Approved diagnostic-only follow-up
  - path: WI-20261011-ATS-050-handoff.md
    reason: Independent local diagnosis before integration
---

# WI-20261011-ATS-051 Handoff

> Purpose: Integrate the bounded local POST_STATE_CHANGED diagnosis without changing historical trial evidence or runtime readiness.

[WI HEADER]
WI ID: WI-20261011-ATS-051
REQ: REQ-20261011-ATS-006
Agent: docops
Depends On: WI-20261011-ATS-050 completion
Blocks: None within this diagnostic-only follow-up

[WI SUMMARY]
Authority: The latest user request authorizes cause investigation, explicitly excluding app rerun and external exposure. It does not authorize a repair or another native trial. See WI050 for the exact quote.
Scope: Append that follow-up and the completed PG findings to REQ006, add a concise current entry to docs/index.md, and produce this WI's evidence pack and summary. Preserve all earlier checkpoints and consumed native receipts.
DoD: Distinguish proven failed phase, deterministic checker limitations, upstream-supported hypotheses and unavailable historical comparison values. Explain no-native/no-secret/no-new-cost boundary and the local-only next recommendation, not execution authority.
Forbidden: Source/candidate/freeze/test changes, historical receipt rewrites, SSH/UI/cloud access, service/app/DB operations, secret use, purchases, commits/push, and claiming exact native cause or unchanged database without evidence. Original REQ006 remains active/HOLD.

[ACCEPTANCE CRITERIA]
- [ ] WI050 completed evidence, rather than anticipated conclusions, is integrated.
- [ ] A fresh reader finds the current diagnostic result and its limitations first.
- [ ] Earlier recovery/access closeout and trial failure evidence remain intact.
- [ ] Selected-document validation and scoped whitespace checks pass; pre-existing unrelated issues are not repaired.

[INPUT POINTERS]
Tier 0: docs/standards/core-principles.md; docs/standards/documentation-standards.md; docs/standards/development-standards.md; docs/standards/glossary.md. Retained MA-injected content applies to the same reused DocOps agent.
Tier 1: docs/policies/security-policy.md, documentation-only/no-secret constraints; .claude/agents/docops.md.
Tier 2: docs/index.md; deliverables/user/REQ-20261011-ATS-006.md; WI050 completed evidence pack and summary; WI045 latest evidence pack and native receipt for historical boundaries only.
Skills: create-wi-handoff-packet (MA invoked); validate-docs; create-wi-evidence-pack.

[OUTPUT CONTRACT]
Allowed writes only: docs/index.md; deliverables/user/REQ-20261011-ATS-006.md; deliverables/agent/WI-20261011-ATS-051-evidence-pack.md; deliverables/user/WI-20261011-ATS-051-summary.md. Use apply_patch. Do not edit WI050 reports or any historical native receipt. Keep the new entries concise; no broad registry updates.

[TRACEABILITY REQUIREMENTS]
Source findings are owned by PG050 and MA local review on 2026-10-11 KST, not fresh target verification. Record selected-file validation and exact changed paths. No rollback needed outside documentation. On completion, report the original REQ HOLD and no next WI within this scope; any implementation or native trial requires a separate user decision.

MA routing continuation: The initial DocOps worker produced the four scoped files but was interrupted before final validation recording. The reused WI050 worker now acts in the DocOps role only to finish WI051 reporting from MA's actual validation receipts. No new technical review, operational action or expanded write scope is delegated. MA selected-document receipt 5fd6ba: eight files, zero errors/warnings, 91 supported IDs; direct newline/trailing-whitespace receipt 2e6598: eight PASS. Preserve the initial worker's draft findings and do not claim an unavailable before/after historical check as completed.
